title: Assessing HCFA's Health Care Quality Improvement Program.
abstract: BACKGROUND
  In 1992 the Health Care Financing Administration introduced the Health Care Quality Improvement Program (HCQIP), through which quality improvement projects are conducted in partnership with quality improvement organizations (QIOs), hospitals, health plans, or physicians. An evaluation of HCQIP began in May 1996 in response to the QIOs' request for an independent assessment of their activities.
  
  
  METHODS
  The methodology and objectives of the evaluation were determined by an independent panel. The QIOs' full cohort of 970 HQIP projects could not be reviewed in the 10-month time frame available, but two topics were chosen: the management of warfarin or aspirin in patients with atrial fibrillation and the management of community-acquired pneumonia.
  
  
  RESULTS
  Analyses were limited to the 49 of the 68 projects that had progressed to the "improvement plan implemented" stage. However, only 39 of these 49 projects had information on outcomes, organization changes, and/or changes in process of care--and only 20 of the 49 had moved beyond the "improvement plan implemented" phase. Feedback of data led hospitals collaborating on improvement projects to revise or create processes of care.
  
  
  CONCLUSIONS
  Although the assessment is the most comprehensive of its type to date, it should be viewed as a pilot study of some of the methods that could be incorporated in a more extensive and rigorous future evaluation of the impact of the HCQIP projects. Specific recommendations include random sampling of HCQIP projects across all clinical areas, conducting both prospective and retrospective assessments, developing uniform process and outcome program impact measures, and developing sustainable, ongoing automated data abstraction and analysis systems.
authors.affiliation: Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, USA.
authors.forename: M A
authors.initials: MA
authors.lastname: Cleves
authors.forename: J P
authors.initials: JP
authors.lastname: Weiner
authors.forename: W
authors.initials: W
authors.lastname: Cohen
authors.forename: C
authors.initials: C
authors.lastname: Athon
authors.forename: N
authors.initials: N
authors.lastname: Banks
authors.forename: L
authors.initials: L
authors.lastname: Boress
authors.forename: D W
authors.initials: DW
authors.lastname: Bratzler
authors.forename: C
authors.initials: C
authors.lastname: Cangialose
authors.forename: G
authors.initials: G
authors.lastname: Zaar
authors.forename: D M
authors.initials: DM
authors.lastname: Ziegenhagen
mesh_terms: D001281:Atrial Fibrillation / Q000188:drug therapy; D014487:Centers for Medicare and Medicaid Services, U.S. / Q000592:standards*; D017714:Community-Acquired Infections / Q000628:therapy; D005069:Evaluation Studies as Topic; D006302:Health Services Research / Q000379:methods*; D006801:Humans; D010865:Pilot Projects; D011014:Pneumonia / Q000628:therapy; D015397:Program Evaluation; D017749:Total Quality Management / Q000592:standards*; D014481:United States